Here, we review the existing and emerging interventions for PD with focus on newly approved and investigational drugs for motor symptoms, motor fluctuations, dyskinesia, and balance and gait dysfunction.Similar content being viewed by others Therapeutic Strategies to Treat or Prevent Off Episodes in ...
the researchers used the Drugs@FDA database to identify all novel therapeutics approved by the FDA between January 1, 2001, and December 31, 2010. They then separated the drugs on the basis on seven prespecified features: class (
as well as a thorough English language literature search from 2020 to July 2023 across multiple databases (PubMed, MEDLINE, Springer Nature, Google Scholar and Cochrane) for various keywords (alone and in combination) such as "FDA approved" OR "recent advances in therapy" OR "recent drugs" OR...
The data for the newly-approved drugs were wearisome to locate. Since the drugs are relatively new, there are not many journal publications reporting properties of the compounds. Most of the data were found in FDA documents. As part of the New Drug Application (NDA) process, the FDA Center...
These drugs are approved for weight loss, and maintenance of weight loss, long term," Kushner explained. Although the long-term implications of taking the higher dose of the drug are still unknown, there have been relatively few side effects of the lower-dose version of semaglutide treat...
The US Food and Drug Administration (FDA)approvedbrexanolone injection on March 19 for the treatment of PPD in adult women, noting that "this is the first drug approved by the FDA specifically for PPD." In the current analysis, Robert Lasser, MD, a psychiatrist at Sage Therapeutics, Cambri...
The survey also revealed a widespread lack of understanding about the meaning of FDA approval for a new drug, the researchers reported. For example, about seven in 10 believed FDA approval meant comparable effectiveness to other approved drugs, and statistically significant and clinically important eff...
Zhang, Y., Wagner, A.K. & Guan, X. Newly approved cancer drugs in China — innovation and clinical benefit. Nat Rev Clin Oncol (2023). https://doi.org/10.1038/s41571-023-00728-3 版权信息 本文系AIDD Pro接受的外部投稿,文中所述观点仅代表作者本人观点,不代表AIDD Pro平台,如您发现发布内容...
"I do keep abreast of research. I need to because sometimes even doctors don't know what's going on," Booker said. "I worry that these new drugs will be too expensive for patients to afford or, worse, they won't know about them." ...
1. FDA approves quizartinib for newly diagnosed acute myeloid leukemia. News release. July 20, 2023. Accessed July 20, 2023. https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-quizartinib-newly-diagnosed-acute-myeloid-leukemia 2. Erba HP, Monetesinos P, Kim HJ, et al. Qui...